[1]
J. K. . Yamamoto-Furusho y A. . Sarmiento-Aguilar, «Efficacy of combination therapy with anti-tumor necrosis factor and immunomodulators in inflammatory bowel disease», IBDR, vol. 3, n.º 1, nov. 2022.